News | February 28, 2022
Mankind Pharma completes acquisition of Panacea Biotec’s domestic business for Rs 1872 cr
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
The facility is spread across 215000 sq. feet and provides super-speciality care
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Application based on the pivotal Phase 3 TRANSFORM study in which Breyanzi showed significant and clinically meaningful improvements over salvage chemotherapy followed by high-dose chemotherapy plus autologous stem cell transplant, which has been the standard of care for more than 20 years
On track to complete the BLA submission in the first half of 2022
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
The hospital has recently launched Radionuclide therapy
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
Subscribe To Our Newsletter & Stay Updated
